NASDAQ:CDIO Cardio Diagnostics (CDIO) Stock Price, News & Analysis → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free CDIO Stock Alerts $0.75 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.73▼$0.7950-Day Range$0.75▼$1.8352-Week Range$0.17▼$3.56Volume117,609 shsAverage Volume327,001 shsMarket Capitalization$16.19 millionP/E RatioN/ADividend YieldN/APrice Target$1.35 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Cardio Diagnostics alerts: Email Address Cardio Diagnostics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside80.0% Upside$1.35 Price TargetShort InterestHealthy2.53% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.67Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.86 out of 5 starsMedical Sector586th out of 907 stocksDiagnostic Substances Industry7th out of 11 stocks 3.5 Analyst's Opinion Consensus RatingCardio Diagnostics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCardio Diagnostics has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.53% of the float of Cardio Diagnostics has been sold short.Short Interest Ratio / Days to CoverCardio Diagnostics has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardio Diagnostics has recently decreased by 2.56%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldCardio Diagnostics does not currently pay a dividend.Dividend GrowthCardio Diagnostics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CDIO. Previous Next 1.3 News and Social Media Coverage News SentimentCardio Diagnostics has a news sentiment score of -0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cardio Diagnostics this week, compared to 1 article on an average week.Search InterestOnly 11 people have searched for CDIO on MarketBeat in the last 30 days. This is a decrease of -21% compared to the previous 30 days.MarketBeat Follows6 people have added Cardio Diagnostics to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardio Diagnostics insiders have not sold or bought any company stock.Percentage Held by Insiders30.00% of the stock of Cardio Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.06% of the stock of Cardio Diagnostics is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Book Value per Share RatioCardio Diagnostics has a P/B Ratio of 5.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> About Cardio Diagnostics Stock (NASDAQ:CDIO)Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.Read More CDIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDIO Stock News HeadlinesApril 21, 2024 | americanbankingnews.comBenchmark Lowers Cardio Diagnostics (NASDAQ:CDIO) Price Target to $1.35April 9, 2024 | businesswire.comExponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in MichiganApril 25, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 4, 2024 | markets.businessinsider.comCardio Diagnostics Inks Nationwide Telehealth Deal With NavierreApril 4, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with NavierreApril 3, 2024 | finance.yahoo.comCardio Diagnostics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 18, 2024 | msn.comPotential novel biomarkers of coronary heart disease discoveredMarch 14, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific SessionApril 25, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.March 14, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific SessionMarch 6, 2024 | morningstar.comCardio Diagnostics Holdings IncMarch 5, 2024 | msn.comStudy finds coronary artery calcium score is predictive of heart attacks, strokesMarch 5, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular DiseaseFebruary 18, 2024 | investing.comCardio Diagnostics expands HeartRisk platform nationwideFebruary 15, 2024 | stockhouse.comCardio Diagnostics Holdings, Inc. Expands HeartRisk(TM) Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutFebruary 15, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutFebruary 15, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutFebruary 10, 2024 | msn.comCardiovascular disease is the leading cause of death in the Valley. Augusta Health wants to change that.February 7, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart SupercentersFebruary 5, 2024 | finance.yahoo.comHouston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease TestsJanuary 31, 2024 | seekingalpha.comDermTech to lay off 30 more workers as it focuses on melanoma testJanuary 26, 2024 | msn.comCardio Diagnostics files for $17M mixed shelfJanuary 24, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic AdvisorJanuary 8, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in IndiaJanuary 4, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™January 4, 2024 | finance.yahoo.comCORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™January 3, 2024 | businesswire.comAmerican Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart ...See More Headlines Receive CDIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Next Earnings (Estimated)7/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:CDIO CUSIPN/A CIK1870144 Webcardiodiagnosticsinc.com Phone302-281-2147FaxN/AEmployees7Year FoundedN/APrice Target and Rating Average Stock Price Target$1.35 High Stock Price Target$1.35 Low Stock Price Target$1.35 Potential Upside/Downside+80.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,380,000.00 Net MarginsN/A Pretax Margin-49,088.78% Return on Equity-293.34% Return on Assets-131.96% Debt Debt-to-Equity RatioN/A Current Ratio3.29 Quick Ratio3.29 Sales & Book Value Annual Sales$20,000.00 Price / Sales809.63 Cash FlowN/A Price / Cash FlowN/A Book Value$0.14 per share Price / Book5.36Miscellaneous Outstanding Shares21,590,000Free Float15,114,000Market Cap$16.19 million OptionableNot Optionable Beta5.03 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Meeshanthini V. Dogan Ph.D. (Age 35)Co-Founder, CEO & Director Comp: $307.25kMs. Elisa Michael Luqman Esq. (Age 60)J.D., M.B.A., Chief Financial Officer Comp: $275kDr. Robert A. Philibert M.D. (Age 62)Ph.D., Co-Founder, Chief Medical Officer & Director Mr. Timur Dogan Ph.D. (Age 36)Chief Technology Officer Ms. Khullani Abdullahi J.D. (Age 40)Vice President of Revenue & Strategy Key CompetitorsTrinity BiotechNASDAQ:TRIBBiomericaNASDAQ:BMRAOncoCyteNASDAQ:OCXMicroAlgoNASDAQ:MLGOSAI.TECH GlobalNASDAQ:SAIView All CompetitorsInsiders & InstitutionsVontobel Holding Ltd.Bought 12,000 shares on 1/30/2024Ownership: 0.058%Meeshanthini DoganBought 16,481 shares on 8/31/2023Total: $9,064.55 ($0.55/share)Robert PhilibertBought 18,000 shares on 8/28/2023Total: $10,800.00 ($0.60/share)Meeshanthini DoganBought 1,770 shares on 8/25/2023Total: $991.20 ($0.56/share)Robert PhilibertBought 16,000 shares on 8/24/2023Total: $9,600.00 ($0.60/share)View All Insider TransactionsView All Institutional Transactions CDIO Stock Analysis - Frequently Asked Questions Should I buy or sell Cardio Diagnostics stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardio Diagnostics in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CDIO shares. View CDIO analyst ratings or view top-rated stocks. What is Cardio Diagnostics' stock price target for 2024? 2 Wall Street analysts have issued 1-year price objectives for Cardio Diagnostics' shares. Their CDIO share price targets range from $1.35 to $1.35. On average, they predict the company's stock price to reach $1.35 in the next twelve months. This suggests a possible upside of 80.0% from the stock's current price. View analysts price targets for CDIO or view top-rated stocks among Wall Street analysts. How have CDIO shares performed in 2024? Cardio Diagnostics' stock was trading at $2.49 at the beginning of the year. Since then, CDIO stock has decreased by 69.9% and is now trading at $0.75. View the best growth stocks for 2024 here. When is Cardio Diagnostics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, July 1st 2024. View our CDIO earnings forecast. How do I buy shares of Cardio Diagnostics? Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CDIO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
